CN111902410B - 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 - Google Patents
用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 Download PDFInfo
- Publication number
- CN111902410B CN111902410B CN201980017700.2A CN201980017700A CN111902410B CN 111902410 B CN111902410 B CN 111902410B CN 201980017700 A CN201980017700 A CN 201980017700A CN 111902410 B CN111902410 B CN 111902410B
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- appropriate
- appropriate amount
- base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Life Sciences & Earth Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410363182.2A CN118184645A (zh) | 2018-01-10 | 2019-01-10 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
| CN202410363184.1A CN118221665A (zh) | 2018-01-10 | 2019-01-10 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862615678P | 2018-01-10 | 2018-01-10 | |
| US62/615,678 | 2018-01-10 | ||
| CNPCT/CN2018/076982 | 2018-02-22 | ||
| PCT/CN2018/076982 WO2019161534A1 (en) | 2018-02-22 | 2018-02-22 | Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators |
| PCT/US2019/013060 WO2019140095A1 (en) | 2018-01-10 | 2019-01-10 | Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410363184.1A Division CN118221665A (zh) | 2018-01-10 | 2019-01-10 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
| CN202410363182.2A Division CN118184645A (zh) | 2018-01-10 | 2019-01-10 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111902410A CN111902410A (zh) | 2020-11-06 |
| CN111902410B true CN111902410B (zh) | 2024-04-19 |
Family
ID=65279655
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980017700.2A Active CN111902410B (zh) | 2018-01-10 | 2019-01-10 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
| CN202410363184.1A Pending CN118221665A (zh) | 2018-01-10 | 2019-01-10 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
| CN202410363182.2A Pending CN118184645A (zh) | 2018-01-10 | 2019-01-10 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410363184.1A Pending CN118221665A (zh) | 2018-01-10 | 2019-01-10 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
| CN202410363182.2A Pending CN118184645A (zh) | 2018-01-10 | 2019-01-10 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US11274096B2 (enExample) |
| EP (3) | EP4249469A3 (enExample) |
| JP (2) | JP7357621B2 (enExample) |
| KR (3) | KR102739727B1 (enExample) |
| CN (3) | CN111902410B (enExample) |
| AU (3) | AU2019206560B2 (enExample) |
| CA (1) | CA3087943A1 (enExample) |
| CL (3) | CL2020001814A1 (enExample) |
| ES (1) | ES2963447T3 (enExample) |
| IL (3) | IL275748B2 (enExample) |
| JO (1) | JOP20200165A1 (enExample) |
| MA (2) | MA71753A (enExample) |
| MX (3) | MX2020007364A (enExample) |
| SG (1) | SG11202006311SA (enExample) |
| TW (2) | TWI821237B (enExample) |
| WO (1) | WO2019140095A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102487872B1 (ko) | 2016-07-07 | 2023-01-12 | 사이클리온 테라퓨틱스, 인크. | 가용성 구아닐레이트 시클라제 자극제의 신규 제조 방법 |
| CN111902410B (zh) | 2018-01-10 | 2024-04-19 | 赛克里翁治疗有限公司 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
| CN118221651A (zh) * | 2022-12-21 | 2024-06-21 | 广东东阳光药业股份有限公司 | 氟取代的吲唑化合物的晶型及其用途 |
| AU2023412228A1 (en) * | 2022-12-21 | 2025-07-03 | Sunshine Lake Pharma Co., Ltd. | Crystal form of fluorine-substituted indazole compound and use thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105408328A (zh) * | 2013-03-15 | 2016-03-16 | 铁木医药有限公司 | sGC刺激剂 |
| WO2017095697A1 (en) * | 2015-11-30 | 2017-06-08 | Ironwood Pharmaceuticals, Inc. | Solid dispersions comprising a sgc stimulator |
| CN107406422A (zh) * | 2014-09-17 | 2017-11-28 | 铁木医药有限公司 | 作为sGC刺激剂的吡唑衍生物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI532737B (zh) * | 2010-06-30 | 2016-05-11 | 艾諾屋製藥公司 | 可溶性鳥苷酸環化酶（ｓＧＣ）刺激物 |
| WO2015106268A1 (en) * | 2014-01-13 | 2015-07-16 | Ironwood Pharmaceuticals, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS |
| CN107223125B (zh) * | 2014-09-17 | 2019-09-27 | 赛科理音医疗有限公司 | sGC刺激剂 |
| EA201990236A1 (ru) | 2016-07-07 | 2019-08-30 | Сайклерион Терапьютикс, Инк. | Новые способы получения стимуляторов растворимой гуанилатциклазы |
| KR102487872B1 (ko) | 2016-07-07 | 2023-01-12 | 사이클리온 테라퓨틱스, 인크. | 가용성 구아닐레이트 시클라제 자극제의 신규 제조 방법 |
| CN111902410B (zh) | 2018-01-10 | 2024-04-19 | 赛克里翁治疗有限公司 | 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物 |
-
2019
- 2019-01-10 CN CN201980017700.2A patent/CN111902410B/zh active Active
- 2019-01-10 SG SG11202006311SA patent/SG11202006311SA/en unknown
- 2019-01-10 KR KR1020207022640A patent/KR102739727B1/ko active Active
- 2019-01-10 EP EP23187776.2A patent/EP4249469A3/en active Pending
- 2019-01-10 CN CN202410363184.1A patent/CN118221665A/zh active Pending
- 2019-01-10 CA CA3087943A patent/CA3087943A1/en active Pending
- 2019-01-10 MA MA71753A patent/MA71753A/fr unknown
- 2019-01-10 ES ES19703440T patent/ES2963447T3/es active Active
- 2019-01-10 KR KR1020257010603A patent/KR20250048609A/ko active Pending
- 2019-01-10 EP EP25174051.0A patent/EP4570797A3/en active Pending
- 2019-01-10 CN CN202410363182.2A patent/CN118184645A/zh active Pending
- 2019-01-10 KR KR1020247039985A patent/KR20250002720A/ko active Pending
- 2019-01-10 JP JP2020538535A patent/JP7357621B2/ja active Active
- 2019-01-10 TW TW108101044A patent/TWI821237B/zh active
- 2019-01-10 AU AU2019206560A patent/AU2019206560B2/en active Active
- 2019-01-10 MX MX2020007364A patent/MX2020007364A/es unknown
- 2019-01-10 IL IL275748A patent/IL275748B2/en unknown
- 2019-01-10 IL IL319883A patent/IL319883A/en unknown
- 2019-01-10 JO JOP/2020/0165A patent/JOP20200165A1/ar unknown
- 2019-01-10 MA MA051565A patent/MA51565A/fr unknown
- 2019-01-10 IL IL314714A patent/IL314714B1/en unknown
- 2019-01-10 EP EP19703440.8A patent/EP3737679B1/en active Active
- 2019-01-10 TW TW112138274A patent/TWI888947B/zh active
- 2019-01-10 WO PCT/US2019/013060 patent/WO2019140095A1/en not_active Ceased
- 2019-01-10 US US16/961,109 patent/US11274096B2/en active Active
-
2020
- 2020-07-07 CL CL2020001814A patent/CL2020001814A1/es unknown
- 2020-07-13 MX MX2023000044A patent/MX2023000044A/es unknown
- 2020-07-13 MX MX2023000045A patent/MX2023000045A/es unknown
-
2021
- 2021-10-08 US US17/497,352 patent/US11708361B2/en active Active
-
2022
- 2022-04-08 CL CL2022000907A patent/CL2022000907A1/es unknown
- 2022-04-08 CL CL2022000904A patent/CL2022000904A1/es unknown
-
2023
- 2023-04-28 US US18/140,966 patent/US12030874B2/en active Active
- 2023-09-26 JP JP2023162922A patent/JP7744955B2/ja active Active
- 2023-11-22 AU AU2023270260A patent/AU2023270260B2/en active Active
-
2024
- 2024-05-22 US US18/671,182 patent/US12275724B2/en active Active
-
2025
- 2025-03-31 AU AU2025202281A patent/AU2025202281A1/en active Pending
- 2025-04-11 US US19/176,742 patent/US20250361228A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105408328A (zh) * | 2013-03-15 | 2016-03-16 | 铁木医药有限公司 | sGC刺激剂 |
| CN107406422A (zh) * | 2014-09-17 | 2017-11-28 | 铁木医药有限公司 | 作为sGC刺激剂的吡唑衍生物 |
| WO2017095697A1 (en) * | 2015-11-30 | 2017-06-08 | Ironwood Pharmaceuticals, Inc. | Solid dispersions comprising a sgc stimulator |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7744955B2 (ja) | 可溶性グアニル酸シクラーゼ刺激剤を調製するための新規のプロセスおよび中間体 | |
| TW201625634A (zh) | 科帕利普（ｃｏｐａｎｌｉｓｉｂ）及其二鹽酸鹽之合成 | |
| HK40103207A (en) | Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators | |
| EA045335B1 (ru) | Новые способы и промежуточные соединения для получения стимуляторов растворимой гуанилатциклазы | |
| EA052114B1 (ru) | Новые способы и промежуточные соединения для получения стимуляторов растворимой гуанилатциклазы | |
| EA048211B1 (ru) | Новые способы и промежуточные соединения для получения стимуляторов растворимой гуанилатциклазы | |
| HK40031722A (en) | Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators | |
| HK40031722B (en) | Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators | |
| WO2019161534A1 (en) | Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators | |
| BR112020013985B1 (pt) | Novos processos e intermediários para a preparação de estimulantes de guanilato ciclase solúvel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |